siRNA, Anti-FMNL2, 2'-F/2'-MOE/LNA/Ribo-modified(CAT#: SIRGT62658WQ-2F)
The product SIRGT62658WQ-2F is a type of small interfering RNA (siRNA) that targets FMNL2 gene and regulates the expression of gene. The siRNA interferes with the expression of FMNL2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_052905.3 |
| Alternative Names | FHOD2 |
| Related Diseases | Malignant Breast Melanoma |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT63658WQ-2MOE | FMNL2 | Human | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT64658WQ-LNA | FMNL2 | Human | Locked Nucleic Acid (LNA) | ||
| SIRGT61658WQ-RB | FMNL2 | Human | Ribo-modified |
